Wiley Matthew T.
Insider CIK 1759703 · MNLO Chief Commercial Officer · FOMX Chief Commercial Officer · BTAI Chief Commercial Officer · DFTX Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DFTX Definium Therapeutics, Inc | S Sale | 2026-09-25 | 2026-09-29 | 3,097 | $36.57 | $113.3K | 359,036 | SEC↗ |
| DFTX Definium Therapeutics, Inc | S Sale | 2026-09-25 | 2026-09-29 | 3,097 | $36.57 | $113.3K | 359,036 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-09-14 | 2026-09-14 | 125,000 | — | $0 | 362,133 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-09-14 | 2026-09-14 | 125,000 | — | $0 | 362,133 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-08-12 | 2026-08-12 | 62,500 | — | $0 | 237,133 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-08-12 | 2026-08-12 | 62,500 | — | $0 | 237,133 | SEC↗ |
| DFTX Definium Therapeutics, Inc | S Sale | 2026-06-25 | 2026-06-26 | 2,867 | $45.03 | $129.1K | 174,633 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-06-22 | 2026-06-22 | 62,500 | — | $0 | 177,500 | SEC↗ |
| DFTX Definium Therapeutics, Inc | A Award | 2026-02-03 | 2026-02-05 | 115,000 | — | $0 | 115,000 | SEC↗ |
| MNMD Mind Medicine (MindMed) In | A Award deriv | 2025-03-17 | 2025-03-18 | 350,000 | — | $0 | 350,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2024-10-03 | 2024-10-03 | 6,272 | $0.55 | $3.4K | 19,011 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award | 2024-09-17 | 2024-10-03 | 21,250 | — | $0 | 25,283 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2024-09-16 | 2024-09-17 | 215 | $0.69 | $148 | 4,033 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-09-15 | 2024-09-17 | 750 | — | $0 | 7,500 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-09-15 | 2024-09-17 | 750 | — | $0 | 4,248 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2024-07-22 | 2025-04-01 | 1,875 | — | $0 | 1,875 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2024-06-17 | 2024-06-18 | 244 | $1.26 | $307 | 3,498 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-06-15 | 2024-09-17 | 750 | — | $0 | 8,250 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-06-15 | 2024-06-18 | 750 | — | $0 | 8,250 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-06-15 | 2024-06-18 | 750 | — | $0 | 3,742 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | S Sale | 2024-04-04 | 2024-04-08 | 1,008 | $2.64 | $2.7K | 2,992 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise deriv | 2024-03-15 | 2024-04-08 | 3,000 | — | $0 | 9,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | M Exercise | 2024-03-15 | 2024-04-08 | 3,000 | — | $0 | 3,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2023-03-15 | 2023-03-16 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2023-03-15 | 2023-03-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2022-01-17 | 2022-01-19 | 85,000 | — | $0 | 85,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-06-30 | 2021-07-02 | 5,151 | $3.51 | $18.1K | 109,246 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-03-31 | 2021-04-02 | 2,573 | $6.84 | $17.6K | 114,397 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-02-22 | 2021-02-24 | 64,575 | — | $0 | 64,575 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-02-22 | 2021-02-24 | 27,675 | — | $0 | 116,970 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2020-12-31 | 2021-01-05 | 1,541 | $1.58 | $2.4K | 357,181 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2020-11-30 | 2020-12-02 | 7,838 | $1.45 | $11.4K | 358,722 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2020-09-30 | 2020-10-02 | 1,541 | $1.66 | $2.6K | 350,884 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-06-30 | 2020-07-02 | 1,541 | $1.73 | $2.7K | 352,425 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-05-06 | 2020-05-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-05-06 | 2020-05-08 | 150,000 | — | $0 | 353,967 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-04-06 | 2020-04-07 | 908 | $1.40 | $1.3K | 203,967 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 91,430 | — | $0 | 204,875 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 46,394 | — | $0 | 113,445 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-03-31 | 2020-04-02 | 525 | $2.68 | $1.4K | 67,051 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 100,000 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 96,365 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 59,240 | — | $0 | 59,240 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 57,086 | — | $0 | 57,086 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 35,275 | — | $0 | 78,799 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 78,799 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 46,680 | — | $0 | 67,576 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 20,896 | — | $0 | 20,896 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2020-03-02 | 2020-03-03 | 1,993 | $2.68 | $5.3K | 114,074 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2020-02-24 | 2020-02-24 | 96,365 | — | $0 | 96,365 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2020-02-24 | 2020-02-24 | 41,299 | — | $0 | 112,081 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | F Tax w/h | 2019-12-31 | 2020-01-03 | 2,500 | $3.28 | $8.2K | 70,782 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2019-11-29 | 2019-12-03 | 9,842 | $2.16 | $21.3K | 73,282 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | P Buy | 2019-03-05 | 2019-03-06 | 13,440 | $3.76 | $50.5K | 63,440 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2018-12-03 | 2018-12-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2018-12-03 | 2018-12-04 | 50,000 | — | $0 | 50,000 | SEC↗ |